Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Apoorva Gogna"'
Autor:
Audrey Qi Xin Chia, Apoorva Gogna, Angela Maria Takano Pena, Vishnu Vemula Sri Sai, Sivanathan Chandramohan, Shaun Ju Min Xavier Chan, Boon-Hean Ong
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-14 (2024)
Abstract Background Video-assisted thoracoscopic (VATS) lung resections are increasingly popular and localization techniques are necessary to aid resection. We describe our experience with hybrid operating room (OR) cone-beam computed tomography (CT)
Externí odkaz:
https://doaj.org/article/96a411531cfe40bdb0c6b34ba2dc11ce
Autor:
Kaina Chen, Aaron K.T. Tong, Fiona N.N. Moe, David C.E. Ng, Richard H.G. Lo, Apoorva Gogna, Sean X. Yan, Sue Ping Thang, Kelvin S.H. Loke, Nanda Karaddi Venkatanarasimha, Hian Liang Huang, Chow Wei Too, Timothy S.K. Ong, Eng Xuan Yeo, Daniel Yang Yao Peh, Ashley W.Y. Ng, Lu Yang, Wan Ying Chan, Jason P.E. Chang, Brian K.P. Goh, Han Chong Toh, Pierce K.H. Chow
Publikováno v:
Liver Cancer, Pp 1-1 (2024)
Introduction Transarterial radioembolisation (RE) using yttrium-90 (Y-90) microspheres is a widely used locoregional therapy for a broad spectrum of HCC given its favourable safety profile. We evaluated the real-world outcomes of unresectable HCC tre
Externí odkaz:
https://doaj.org/article/8f883bf9ef634e429bc4b43b9328f845
Autor:
Hiang Keat Tan, Alfred Bingchao Tan, Kevin Kim Jun Teh, Apoorva Gogna, Chow Wei Too, Sum Leong, Jason Pik Eu Chang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Hepatic venous pressure gradient (HVPG) is an accurate measure of portal hypertension in cirrhosis. However, the effect of catheter tip distance from hepatic vein ostium (HVO) on HVPG is unknown. We performed a retrospective study on 228 pat
Externí odkaz:
https://doaj.org/article/c4b14a43ed7e437099e764e0eadf8226
Publikováno v:
Diagnostic and Interventional Radiology, Vol 29, Iss 2, Pp 318-325 (2023)
Percutaneous thermal ablation of hepatic tumors is accepted as a safe, reliable, and cost-effective therapeutic option for treating hepatocellular carcinoma and hepatic metastases. However, operators should be familiar with the myriad of vascular and
Externí odkaz:
https://doaj.org/article/6bedcc036cd448b09594c94ee457b2b7
Publikováno v:
CVIR Endovascular, Vol 5, Iss 1, Pp 1-9 (2022)
Abstract Learning objective To share our experience in utilising the triple coaxial (triaxial) system in superselective cannulation of arteries for complex embolisation procedures. Background Percutaneous transcatheter selective embolisation is widel
Externí odkaz:
https://doaj.org/article/e76df4deb7fd459e8a0abff4b6c0bb13
Autor:
David Tai, Fei Yao, Joycelyn Lee, Su Pin Choo, Joe Yeong, Jeffrey Chun Tatt Lim, Han Chong Toh, Xinru Lim, Jiangfeng Ye, Denise Goh, Tony Kiat-Hon Lim, Mai Chan Lau, Timothy Wai Ho Shuen, Weiwei Zhai, Jia Qi Lim, Lawrence Cheung, Neslihan Arife Kaya, Cheryl Zi Jin Phua, Felicia Yu Ting Wee, Craig Ryan Joseph, Zhen Wei Neo, Kelvin S H Loke, Apoorva Gogna, May Yin Lee, Axel Hilmer, Yun Shen Chan, Wai Leong Tam
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Combination therapy with radioembolization (yttrium-90)-resin microspheres) followed by nivolumab has shown a promising response rate of 30.6% in a Phase II trial (CA209-678) for advanced hepatocellular carcinoma (HCC); however, the respon
Externí odkaz:
https://doaj.org/article/14c8d7451ab74713956c9bc91a18b071
Autor:
Tjun Y Tang, Charyl JQ Yap, Shereen XY Soon, Ru Yu Tan, Suh Chien Pang, Ankur Patel, Apoorva Gogna, Chieh Suai Tan, Tze Tec Chong
Publikováno v:
CVIR Endovascular, Vol 5, Iss 1, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/9a7d650c67de4cc984f2b7046dd16bc0
Autor:
Shiqi Chung, Apoorva Gogna, Sivanathan Chandramohan, Richard Lo, Farah Gillan Irani, Nanda Venkatanarasimha
Publikováno v:
Proceedings of Singapore Healthcare, Vol 32 (2023)
Background A systematic review of the outcomes of combination therapy using Yttrium 90 radioembolization (Y90) and sorafenib/nivolumab for patients with hepatocellular carcinoma (HCC), with hepatic vein (HV) or inferior vena cava (IVC) invasion. The
Externí odkaz:
https://doaj.org/article/cdab07494a12429b91c40aaa11f7a406
Autor:
Suh Chien Pang, Ru Yu Tan, Edward Choke, Jackie Ho, Kiang Hiong Tay, Apoorva Gogna, Farah G. Irani, Kun Da Zhuang, Luke Toh, Shaun Chan, Pradesh Krishnan, Kristen A. Lee, Sum Leong, Richard Lo, Ankur Patel, Bien Soo Tan, Chow Wei Too, Jasmine Chua, Ren Kwang Alvin Tng, Tjun Yip Tang, Siew Ping Chng, Tze Tec Chong, Hsien Ts’ung Tay, Hao Yun Yap, Julian Wong, Rajesh Babu Dharmaraj, Jun Jie Ng, Anil Gopinathan, Eu Kuang Loh, Shao Jin Ong, Gary Yoong, Jia Sheng Tay, Kay Yuan Chong, Chieh Suai Tan
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Percutaneous transluminal angioplasty is the current standard treatment for arteriovenous fistula (AVF) stenosis. The mid- and long-term patency with plain balloon angioplasty (PBA) is however far from satisfactory. While paclitax
Externí odkaz:
https://doaj.org/article/242d3b68878e4c26989a17473144fb1a
A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC
Autor:
Gillianne G.Y. Lai, MBBS, Jia Chi Yeo, PhD, Amit Jain, MBBS, PhD, Siqin Zhou, MSc, Mengyuan Pang, MSc, Jacob J.S. Alvarez, BSc, Ngak Leng Sim, BCS, Aaron C. Tan, MBBS, FRACP, PhD, Lisda Suteja, BSc, Tze Wei Lim, BSc, Yu Amanda Guo, PhD, Meixin Shen, PhD, Stephanie P.L. Saw, MBBS, Neha Rohatgi, BSc, Joe P.S. Yeong, MBBS, PhD, Angela Takano, MBBS, Kiat Hon Lim, MBBS, Apoorva Gogna, MBBS, Chow Wei Too, MBBS, Kun Da Zhuang, MBBS, Wan Ling Tan, MBBS, Ravindran Kanesvaran, MBBS, Quan Sing Ng, MBBS, Mei Kim Ang, MBBS, Tanujaa Rajasekaran, MBBS, Lanying Wang, MBBS, Chee Keong Toh, MBBS, Wan-Teck Lim, MBBS, Wai Leong Tam, PhD, Sze Huey Tan, PhD, Anders M.J. Skanderup, PhD, Eng-Huat Tan, MBBS, Daniel S.W. Tan, BSc, MBBS, MRCP, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 12, Pp 100416- (2022)
Introduction: Although immune checkpoint inhibitors (ICIs) have dramatically improved outcomes for nononcogene-addicted NSCLC, monotherapy with programmed cell death protein-1 (PD1) inhibition has been associated with low efficacy in the EGFR-mutant
Externí odkaz:
https://doaj.org/article/7d3ef7d52e0641cbadf717aeaf522b4b